7 Tips To Get You Ready For JPM 2018
Seven tips to get you ready for attending the 36th Annual J.P. Morgan Healthcare Conference.
Continue Reading..
Why Every Company Needs A Bio Strategy
Today we stand on the precipice overlooking a new frontier — the century of biology, and businesses of all kinds need to be prepared to not only embrace what is coming, but have a strategy for how to leverage biology for the betterment of their businesses and the good of the planet.
Continue Reading..
What Is BIO Hoping To See Among Session Submissions For 2018?
Life Science Leader Chief Editor Rob Wright is cochairing the 2018 BIO educational program planning committee. In this blog he talks about why this was the earliest the planning committee has ever met and what you can do to submit interesting and novel session proposals that will get the attention of the committee.
Continue Reading..
The Essentials Of Your BIO 2018 Educational Session Proposal
Next week, BIO will invite biopharmaceutical industry experts to submit educational topic session proposals for the 2018 BIO International Convention in Boston, June 4 - 7. The 2018 call for sessions and speakers opens on Thursday, September 14, and closes on Thursday, October 12, 2017. As I have (once again) agreed to serve as a BIO educational program planning committee co-chair, I have a vested interest in its success. My goal in helping...
Continue Reading..
My Top 10 Quotes From David Hung, Axovant Sciences CEO
Forbes once called Merck’s Ken Frazier a “quote machine,” but I’d say David Hung is just as deserving of that moniker. I interviewed Hung, the new CEO of Axovant Sciences, at the BIO conference in June, and throughout our discussion I found myself smiling. Hung, who saw the company he founded, Medivation, be acquired by Pfizer for $14.3 billion, will be the subject of a Life Science Leader magazine exclusive feature in...
Continue Reading..
What Do Partnering For Cures And A GSK Plant Tour Have In Common?
In July I had two interesting opportunities. The first was on July 12, 2017 when I attended the Partnering For Cures (Twitter hashtag #FCP4C) conference in Boston. The second took place on July 19, when I got to tour GSK’s vaccine manufacturing facility in Marietta, PA. And while you might not think that a biopharmaceutical conference and a manufacturing facility would have much in common, in actuality they do, as both are focused on...
Continue Reading..
Did You See Any Breakthroughs At BIO?
As usual, the BIO International 2017 Convention was a top-shelf event. This year’s show theme was, “breakthroughs.” And while I didn’t see a single breakthrough therapeutic take center stage at this year’s event, there were still a significant number of them worth noting. For example, in the first can’t-miss session listed in my pre-BIO blog, attendance nearly broke through the walls — literally. Not...
Continue Reading..
How Has Biopharma Arrived At Its Current Lose-Lose Situation?
Drug Sales Reel Amid Probe Into Charities. This was the headline of Jonathan Rockoff’s June 12, 2017, Wall Street Journal article that points out how sales for two U.S. “blockbuster prostate-cancer drugs” (i.e., J&J’s Zytiga and Pfizer’s Xtandi) were down (i.e., 14 and 11 percent respectively) for the first quarter from a year previous. Apparently there are two contributing factors that explain this drop in...
Continue Reading..
3 Can’t Miss Educational Sessions At BIO 2017
As we get closer to one of our industry’s biggest annual gatherings, the BIO International 2017 Convention in San Diego, June 19 – 22, I have begun to pin down my schedule for which educational sessions I plan to attend. For me, this has always been a challenge, as BIO has so much great educational content. And with many of the educational sessions overlapping, I find I have to pick and choose where I want to be, often with at least...
Continue Reading..
Biopharmaceutical Industry CEO Of The Year — An Update
On April 25, 2017, I posted a blog asking the question, Who Is The Biopharmaceutical CEO Of The Year. In the blog, I included a link to a short survey. Our goal was twofold: see if there was enough interest in continuing to pursue such an award, and generate an initial list of names that would be in contention. Thus far, 10 names have been submitted via dozens of submissions, but it’s too early for us to make any decisions or conclusions...
Continue Reading..
Rob Wright
Rob Wright was chief editor of Life Science Leader magazine from 2011-2021. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, moderated, and served as a speaker at industry and academic conferences, and served as co-chair for the 2015 and 2018 BIO International conference’s educational planning committee. Wright’s 500+ published articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a B.S. in Business Administration from Indiana University of Pennsylvania, MBA with distinction from Gannon University, and completed his doctoral coursework in marketing at Cleveland State University. He is a member of international business honor societies Sigma Beta Delta and Beta Gamma Sigma. He can be followed on Twitter @RfwrightLSL
This website uses cookies to ensure you get the best experience on our website. Learn more